Risk Factors Associated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis
Open Access
- 30 November 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (11) , e0167346
Abstract
Henoch-Schönlein purpura (HSP) is an important cause of chronic kidney disease in children. This meta-analysis identified risk factors associated with renal involvement in childhood HSP. PubMed, Embase, and Web of Science were searched. The quality of all eligible studies was assessed using the Newcastle-Ottawa scale criteria. An analysis of possible risk factors was conducted to report the odds ratio (OR) and weighted mean difference (WMD). Thirteen studies (2398 children) revealed 20 possible and 13 significant risk factors associated with renal involvement in HSP, with the following meta-analysis estimates of OR and WMD, with 95% confidence intervals: older age (0.90, 0.61–1.19); age > 10 y (3.13, 1.39–7.07); male gender (1.36, 1.07–1.74); abdominal pain (1.94,1.24–3.04); gastrointestinal bleeding (1.86, 1.30–2.65); severe bowel angina (3.38, 1.17–9.80); persistent purpura (4.02, 1.22–13.25); relapse (4.70, 2.42–9.14); WBC > 15 × 109/L (2.42, 1.39–4.22); platelets > 500 × 109/L (2.98, 1.22–7.25); elevated antistreptolysin O (ASO) (2.17, 1.29–3.64); and decreased complement component 3 (C3) (3.13, 1.62–6.05). Factors not significantly associated with renal involvement were: blood pressure; orchitis; elevated C-reactive protein; elevated erythrocyte sedimentation rate (ESR); and elevated serum IgA/IgE or IgG. Arthritis/arthralgia may be a risk factor according to the criteria of the American College of Rheumatology (1.41, 1.01–1.96). The following are associated with renal involvement in pediatric HSP: male gender; > 10 y old; severe gastrointestinal symptoms (abdominal pain, gastrointestinal bleeding, and severe bowel angina); arthritis/arthralgia; persistent purpura or relapse; WBC > 15 × 109/L; platelets > 500 × 109/L; elevated ASO; and low C3. Relevant clinical interventions for these risk factors may exert positive effects on the prevention of kidney disease during the early stages of HSP. However, the results should be interpreted cautiously due to the limitations of the studies.Keywords
Funding Information
- National Natural Science Foundation of China (81270802, 81470946)
- National Natural Science Foundation of China (81200520)
This publication has 48 references indexed in Scilit:
- Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomesPediatric Nephrology, 2011
- Henoch-Schönlein Purpura NephritisClinical Journal of the American Society of Nephrology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP)2009
- Henoch-Schönlein PurpuraJCR: Journal of Clinical Rheumatology, 2008
- Endoscope Images of Schönlein-Henoch PurpuraDigestion, 2008
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationPLOS Medicine, 2007
- Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of initial prognostic factorsJornal de Pediatria, 2007
- Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch–Schönlein purpuraScandinavian Journal of Rheumatology, 2006
- Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosisClinical Nephrology, 2003